Quarterly report [Sections 13 or 15(d)]

STOCK-BASED COMPENSATION (Tables)

v3.26.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
SUMMARY OF STOCK-BASED COMPENSATION EXPENSE RECOGNIZED FOR STOCK OPTION AWARDS

The Company has recorded stock-based compensation expense related to the issuance of restricted stock awards in the following line items in the accompanying condensed consolidated statements of operations:

 

    2026     2025  
   

Three Months Ended March 31,

 
    2026     2025  
             
Research and development   $ 1,074     $ 21,250  
General and administrative     13,266       305,366  
Total stock-based compensation expense   $ 14,340     $ 326,616  
SUMMARY OF OPTION ACTIVITY

The following table summarizes stock option activity under the 2014 Plan and 2024 Plan:

 

   

Number of

options

   

Weighted-average

exercise price

   

Weighted-average

 remaining contractual

term (in years)

   

Aggregate

intrinsic value

 
Outstanding at December 31, 2025     9,055     $ 211.56       3.67        
Granted                        
Exercised                        
Forfeited                        
Outstanding at March 31, 2026     9,055     $ 211.56       3.42        
                                 
Vested and exercisable at March 31, 2026     9,055     $ 211.56       3.42        
SUMMARY OF RESTRICTED STOCK AWARD

The following table summarizes restricted stock award activity under the 2014 Plan and 2024 Plan:

 

    Number of                 As of March 31, 2026  
   

restricted

stock awards

(RSA)

   

Weighted-

average

grant price

   

FMV on

grant date

   

Vested

number

of RSA

   

Unvested

number

of RSA

 
Balance at December 31, 2025     51,810     $ 51.87     $ 2,709,982       47,951       3,859  
Granted                              
Forfeited                              
Balance at March 31, 2026     51,810     $ 51.87     $ 2,709,982       47,951       3,859